6-prenylnaringenin
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2016 (NCT03140397)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Cytochrome P450 1B1ACTIVATOR
CYP1B1 activator
- Cytochrome P450 1A1ACTIVATOR
CYP1A1 activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- 6-prenylnaringenin
- 6-prenylnaringenin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03286777 | N/A | Jun 22, 2017 | University of Hohenheim, University of Tuebingen |
| NCT03140397 | Early Phase 1 (Phase 1) | Jan 1, 2016 | University of Hohenheim, University of Tuebingen |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Hohenheim | Academic/Hospital | 2 | 2 | 2 | 2016 |
| University of Tuebingen | Academic/Hospital | 2 | 0 | 2 | 2016 |
2 organizations
Page 1 / 1